Skip Navigation
National Cancer Institute

Research-Practice Partnerships

Research-practice partnerships are essential for integrating evidence-based practices, programs and interventions into health care and public health settings. The Implementation Science (IS) team is actively involved in several partnerships to facilitate and encourage collaboration between research and practice communities, as described below.

Research to Reality (R2R)

Research to Reality (R2R) is an online community of practice designed to bring together cancer control practitioners and researchers to discuss moving evidence-based programs into practice. Developed and supported by the National Cancer Institute (NCI), this community is both an information resource and a forum where members can connect and collaborate with other public health professionals to ask questions, discuss ideas and solutions, share useful resources and tools, and participate in cyber-seminars and other events. Currently, R2R has over 2,300 members.

R2R was developed in response to Cancer Control P.L.A.N.E.T. users' need to have a better, timelier way to engage their colleagues and share experiences. We invite you to join the dialogue through several interactive features including discussions, cyber seminars , and featured R2R partners.

  • IS Team Role: The IS team contributes to the site by providing information on upcoming cyber-seminars, moderating discussions on relevant and timely topics, and sharing new resources and tools. Most of the content on the portal, however, is user generated, with the ultimate goal of forming a self-sustaining and vibrant community dialogue.
  • IS Team Lead: Margaret M. Farrell, MPH, RD

Cancer Prevention and Control Research Network (CPCRN)

The Cancer Prevention and Control Research Network exit disclaimer (CPCRN) is a national network of academic, public health, and community partners who work together to reduce the burden of cancer, especially among those disproportionately affected. The CPCRN was initiated in October 2002, with funding from the Centers for Disease Control and Prevention (CDC) and the National Cancer Institute (NCI) as part of their efforts to more effectively translate research into practice. It is a thematic research network of the Prevention Research Centers (PRCs), which is the CDC flagship program for preventing and controlling chronic diseases. By drawing on the established PRC guidelines and strong community ties, the CPCRN conducts community-based, participatory cancer research across its 8 network centers, regardless of academic affiliations and geographic boundaries. CPCRN Network Centers undertake cross-site projects, described on the Workgroups exit disclaimer page, that pursue the overall objective of extending our knowledge base of translation processes, measures and outcomes for evidence-based cancer control activities and developing partnerships with major national systems and networks. Having a network with broad geographic reach and strong relationships among investigators allows us to achieve more than any individual center could achieve on its own. Currently, the CPCRN is comprised of 8 funded research institutions and one funded coordinating center, including: Case Western Reserve University, Oregon Health & Science University, University of Iowa, University of Kentucky, University of North Carolina at Chapel Hill, University of Pennsylvania, University of South Carolina at Columbia Arnold School of Public Health, and the University of Washington. Over 235 members participate in CPCRN, including 26 physicians and 131 individuals with doctoral degrees.

  • IS Team Role: The IS team works with CPCRN investigators and the coordinating center to facilitate community-based, participatory cancer research to advance implementation science
  • IS Team Lead: Cynthia A. Vinson, PhD, MPA

Comprehensive Cancer Control National Partnership (CCCNP)

NCI is one of 16 organizations working together in the area of Comprehensive Cancer Control. Other organizations include: American Cancer Society, exit disclaimer American Cancer Society-Cancer Action Network, exit disclaimer American Legacy Foundation, exit disclaimer Association of State and Territorial Health Officials, exit disclaimer C-Change, exit disclaimer Centers for Disease Control and Prevention, Commission on Cancer, exit disclaimer Intercultural Cancer Coalition, exit disclaimer LiveSTRONG, exit disclaimer Leukemia Lymphoma Society, exit disclaimer North American Association of Central Cancer Registries, exit disclaimer National Association of County and City Health Officials, exit disclaimer National Association of Chronic Disease Directors, exit disclaimer and Susan G. Komen. exit disclaimer Since 1999, the Comprehensive Cancer Control National Partnership exit disclaimer (CCCNP) has come together to support the development and implementation of comprehensive cancer control plans in states, tribes and territories. Phases 1 through 3 of this initiative have resulted in various tools, guidance documents and technical assistance opportunities, such as the CCC Leadership Institutes. Phases 1-3 were successful in assisting with the development of CCC plans and the implementation of priority planning strategies. Phase 4 of the CCCNP initiative is designed to continue the fostering of networks among CCC coalitions and to drive action plans that will result in further implementation of CCC plan priority strategies. The CCCNP has chosen the following priorities for Phase 4: Policy Impacting CCC Efforts; Resources for Implementation of CCC Plans; CCC Implementation at the Local Level; and National Partner Communications.

  • IS Team Role: The IS team works with the CCCNP to encourage the use of evidence-based interventions and implementation strategies to support state, tribe and Pacific Island jurisdiction cancer control plans and programs. 
  • IS Team Lead: Margaret M. Farrell, MPH, RD

International Cancer Control Partnership (ICCP)

For the first time, key international organizations have joined together to coordinate their efforts to support national cancer control plan development and implementation. The International Cancer Control Partnership exit disclaimer (ICCP), formed in November 2012, is a group of organizations whose members were already individually working to support country cancer control planning efforts. Now, these organizations will work together on identified priorities to maximize their collective resources and avoid duplication of effort. The long-term outcome that the ICCP is working towards is that all countries have and are implementing a quality cancer control plan, which is linked to a country’s non-communicable disease (NCD) control efforts. The ICCP believes that prioritizing cancer is critical to reaching the voluntary goal within the Global Monitoring Framework on NCDs exit disclaimer and the WHO Global NCDs Action Plan 2013-2020: exit disclaimer a 25% reduction in premature mortality from non-communicable diseases (cancer, cardiovascular diseases, diabetes, and chronic respiratory diseases) by 2025.

  • IS Team Role: The IS team works with the ICCP in providing technical support and resources related to evidence-cancer control planning and evaluation and helping countries identify and support opportunities related to dissemination and implementation research.
  • IS Team Lead: Cynthia Vinson, PhD, MPA